Molecular Cancer Therapeutics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

About the Cover

Cover Figure


The Cover
Treatment of 9L glioma cells with CP248, a derivative of Exisulind (sulindac sulfone), disrupts tubulin polymerization and arrests cells in mitosis. This figure displays an abnormal spindle apparatus in CP248-treated cells. Chromosomal DNA is stained blue; microtubules, green; and MAD2, red. For details, see Yoon et al. in this issue.



[Table of Contents]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.